Wealth Preservation Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wealth Preservation Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85K	Buy	+192	New	+$2.81K	﹤0.01%	553

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wealth Preservation Advisors's AUPH Position: Q1 2026 in Review

Wealth Preservation Advisors opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 192 shares worth $2.85K. The stake represents ﹤0.01% of the portfolio and ranks #553 among its holdings.

259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Wealth Preservation Advisors held 192 shares of Aurinia Pharmaceuticals worth $2.85K as of Q1 2026.
Aurinia Pharmaceuticals was a new Wealth Preservation Advisors position in Q1 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #553 holding.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.